comparemela.com

Latest Breaking News On - American society of nephrology kidney week - Page 8 : comparemela.com

Organ donation linked to heightened risk for kidney stone events in Mayo study

Organ donation linked to heightened risk for kidney stone events in Mayo study
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United statesByshawnm carterMindy valcarcelMirat keddisAmerican society of nephrology kidney weekMayo clinic scottsdaleStone clinicAmerican societyNephrology kidney week

Preliminary Data from SPARTAN Trial Presented at ASN 2023

Preliminary data from the SPARTAN study were presented at ASN Kidney Week 2023, demonstrating sparsentan’s impact on proteinuria and total body water over time.

United statesJonathan barrattIga nephropathy foundation jonathan barrattDrug administrationAmerican society of nephrology kidney weekUniversity of leicesterIga nephropathy foundationAmerican societyNephrology kidney weekMayer professorRenal medicineImmunoglobulina nephropathy

Hyperuricemia Less Prevalent Among Adults With Higher Urinary Molybdenum Levels

Molybdenum has antioxidative properties. Investigators studied the relationship between molybdenum and kidney disease outcomes, including hyperuricemia.

United statesBoram weonNutrition examination surveyOffice of dietary supplementsAmerican society of nephrology kidney weekNational healthAmerican societyKidney week

Zibotentan, Dapagliflozin Combo Further Reduces Albuminuria in CKD

ZENITH-CKD is the first randomized trial comparing combined SGLT2 and endothelin A inhibition in patients with chronic kidney disease. Endothelin system blockade with zibotentan is a potential new therapy in chronic kidney disease (CKD).

City ofUnited kingdomUnited statesGavin brian chapmanHiddo lambers heerspinkNeeraj dhaunUniversity of edinburghUniversity medical center groningenAmerican society of nephrology kidney weekAmerican societyKidney week

Benefits Observed With GLP-1RA Use in T2DM With Advanced CKD

The use of glucagon-like peptide-1 receptor agonists appears to be safe and effective in patients with type 2 diabetes mellitus and advanced chronic kidney disease.

United statesAmerican society of nephrology kidney weekAmerican societyKidney week

vimarsana © 2020. All Rights Reserved.